Vitiligo
- PMID: 25596811
- DOI: 10.1016/S0140-6736(14)60763-7
Vitiligo
Abstract
Vitiligo, an acquired pigmentary disorder of unknown origin, is the most frequent cause of depigmentation worldwide, with an estimated prevalence of 1%. The disorder can be psychologically devastating and stigmatising, especially in dark skinned individuals. Vitiligo is clinically characterised by the development of white macules due to the loss of functioning melanocytes in the skin or hair, or both. Two forms of the disease are well recognised: segmental and non-segmental vitiligo (the commonest form). To distinguish between these two forms is of prime importance because therapeutic options and prognosis are quite different. The importance of early treatment and understanding of the profound psychosocial effect of vitiligo will be emphasised throughout this Seminar.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Similar articles
-
A Practical Approach to the Diagnosis and Treatment of Vitiligo in Children.Pediatrics. 2016 Jul;138(1):e20154126. doi: 10.1542/peds.2015-4126. Epub 2016 Jun 21. Pediatrics. 2016. PMID: 27328922 Review.
-
Vitiligo: A Review.Dermatology. 2020;236(6):571-592. doi: 10.1159/000506103. Epub 2020 Mar 10. Dermatology. 2020. PMID: 32155629 Review.
-
Disorders of Hypopigmentation.J Drugs Dermatol. 2019 Mar 1;18(3):s115-s116. J Drugs Dermatol. 2019. PMID: 30909355
-
Vitiligo: an update on current pharmacotherapy and future directions.Expert Opin Pharmacother. 2012 Sep;13(13):1885-99. doi: 10.1517/14656566.2012.712113. Epub 2012 Jul 27. Expert Opin Pharmacother. 2012. PMID: 22835073 Review.
-
Vitiligo nonsurgical treatment: a review of latest treatment researches.Dermatol Ther. 2014 Sep-Oct;27(5):298-303. doi: 10.1111/dth.12143. Epub 2014 Jul 12. Dermatol Ther. 2014. PMID: 25041437 Review.
Cited by
-
Mechanisms of autophagy and their implications in dermatological disorders.Front Immunol. 2024 Nov 4;15:1486627. doi: 10.3389/fimmu.2024.1486627. eCollection 2024. Front Immunol. 2024. PMID: 39559368 Free PMC article. Review.
-
Review of Microneedle Technology for Targeted Therapeutics in Vitiligo: Design Principles, Application Prospects.Drug Des Devel Ther. 2024 Nov 3;18:4901-4914. doi: 10.2147/DDDT.S449381. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39512266 Free PMC article. Review.
-
Apigenin Ameliorates H2O2-Induced Oxidative Damage in Melanocytes through Nuclear Factor-E2-Related Factor 2 (Nrf2) and Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (Akt)/Mammalian Target of Rapamycin (mTOR) Pathways and Reducing the Generation of Reactive Oxygen Species (ROS) in Zebrafish.Pharmaceuticals (Basel). 2024 Sep 30;17(10):1302. doi: 10.3390/ph17101302. Pharmaceuticals (Basel). 2024. PMID: 39458943 Free PMC article.
-
Short-term (24 weeks) treatment efficacy and safety of ruxolitinib cream in participants with vitiligo: a systematic review and meta-analysis.Syst Rev. 2024 Oct 2;13(1):250. doi: 10.1186/s13643-024-02653-7. Syst Rev. 2024. PMID: 39358803 Free PMC article.
-
Markers of Metabolic Abnormalities in Vitiligo Patients.Int J Mol Sci. 2024 Sep 23;25(18):10201. doi: 10.3390/ijms251810201. Int J Mol Sci. 2024. PMID: 39337683 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
